70
Participants
Start Date
June 3, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Fibrinogen concentration by the qLabs®FIB Monitoring system
A drop of blood (\~15 μL) is taken from the blood sample for the complete haemostasis assessment (prothrombin level, activated partial thromboplastin time, fibrinogen). This assessment is part of the usual management of severe postpartum haemorrhage. It is carried out urgently in the hospital's medical biology laboratory at the start of treatment (T1) and during or at the end of treatment of the haemorrhage (T2). This drop of blood will allow the measurement of the fibrinogen concentration by the qLabs®FIB Monitoring system for the study at these two times.
RECRUITING
Hôpital Cochin Maternité Port Royal, Paris
RECRUITING
Hôpital Necker-Enfants Malades, Paris
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER